{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:22:48Z","timestamp":1778300568455,"version":"3.51.4"},"reference-count":43,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2011,11,15]],"date-time":"2011-11-15T00:00:00Z","timestamp":1321315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Breastfeeding Medicine"],"published-print":{"date-parts":[[2012,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Breastfeeding has numerous maternal and infant benefits. Progesterone contraception after birth is frequently recommended, but because a decrease in progesterone is required to initiate lactation, early postpartum progesterone contraception use could inhibit lactation. The purpose of this article is to critically evaluate the scientific basis for conflicting clinical recommendations related to postpartum medroxyprogesterone use among breastfeeding women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Relevant peer-reviewed literature was identified through a comprehensive search of PubMed through December 2010. The search was restricted to clinical trials, randomized clinical trials, or comparative studies written in English and conducted among humans. The studies included in this review addressed the effect of medroxyprogesterone administration at &lt;6 weeks postpartum on breastfeeding exclusivity and\/or duration and measured breastfeeding outcomes at \u22656 weeks postpartum.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 20 articles identified, only three studies satisfied the inclusion criteria. However, all three studies were of low-quality methodological rigor, and none accounted for potential confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Current evidence is methodologically weak and provides an inadequate basis for inference about a possible causal relationship between early postpartum medroxyprogesterone use and poor breastfeeding outcomes. However, given the presence of a strong biological model describing the potential deleterious effect of postpartum medroxyprogesterone use on lactation, further research that improves on current literature is warranted. Meanwhile, we recommend that potential breastfeeding risks associated with early (&lt;6 weeks) postpartum medroxyprogesterone use be disclosed to allow for a fully informed consent and decision-making process.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/bfm.2011.0105","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T07:30:34Z","timestamp":1321428634000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":22,"title":["A Systematic Review of Early Postpartum Medroxyprogesterone Receipt and Early Breastfeeding Cessation: Evaluating the Methodological Rigor of the Evidence"],"prefix":"10.1177","volume":"7","author":[{"given":"Elizabeth A.","family":"Brownell","sequence":"first","affiliation":[{"name":"University of Rochester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Diana","family":"Fernandez","sequence":"additional","affiliation":[{"name":"University of Rochester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia R.","family":"Howard","sequence":"additional","affiliation":[{"name":"University of Rochester"},{"name":"Rochester General Hospital"},{"name":"University of Rochester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan G.","family":"Fisher","sequence":"additional","affiliation":[{"name":"University of Rochester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon R.","family":"Ternullo","sequence":"additional","affiliation":[{"name":"University of Rochester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.J.","family":"Buckley","sequence":"additional","affiliation":[{"name":"Rochester Institute of Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M.","family":"Dozier","sequence":"additional","affiliation":[{"name":"University of Rochester"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2011,11,15]]},"reference":[{"key":"e_1_3_3_2_2","volume-title":"Medical Eligibility Criteria for Contraceptive Use","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. Medical Eligibility Criteria for Contraceptive Use, 4th. World Health Organization: Geneva, 2009.","edition":"4"},{"key":"e_1_3_3_3_2","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention. U.S. medical eligibility criteria for contraceptive use, 2010. MMWR Recomm Rep, 2010; 59:1\u201386.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_3_4_2","unstructured":"Changes to guidelines for contraceptive use could compromise a woman's ability to breastfeed [press release]. Academy of Breastfeeding Medicine. June 24 2010."},{"key":"e_1_3_3_5_2","volume-title":"DEPO-PROVERA\u00ae contraceptive injection medroxyprogesterone acetate injectable suspension","author":"Pfizer","year":"2006","unstructured":"Pfizer. DEPO-PROVERA\u00ae contraceptive injection medroxyprogesterone acetate injectable suspension. USP. Physician information: Pfizer, New York, 2006."},{"key":"e_1_3_3_6_2","article-title":"U.S. Approves Injectable Drug as Birth Control","author":"Leary WE","year":"1992","unstructured":"Leary WE. U.S. Approves Injectable Drug as Birth Control. The New York Times, 1992 Oct 30.","journal-title":"The New York Times"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(97)00042-5"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.grf.0000139710.63598.b1"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3928\/0090-4481-20030501-11"},{"key":"e_1_3_3_10_2","volume-title":"La Leche League International: The Breastfeeding Answer Book","author":"Mohrbacher N","year":"2003","unstructured":"Mohrbacher N, , Stock J. La Leche League International: The Breastfeeding Answer Book, 3rd. La Leche League International: Schaumburg, IL, 2003.","edition":"3"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-007-9054-4"},{"key":"e_1_3_3_12_2","volume-title":"Breastfeeding the Newborn: Clinical Strategies for Nurses","author":"Biancuzzo M","year":"2003","unstructured":"Biancuzzo M. Breastfeeding the Newborn: Clinical Strategies for Nurses, 2nd. Mosby: St. Louis, 2003.","edition":"2"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2004.08.002"},{"key":"e_1_3_3_14_2","volume-title":"Breastfeeding and Maternal and Infant Health Outcomes in Developed Countries","author":"Ip S","year":"2007","unstructured":"Ip S, , Chung M, , Raman G et al. Breastfeeding and Maternal and Infant Health Outcomes in Developed CountriesEvidence Report\/Technology Assessment No. 153Agency for Healthcare Research and Quality: Rockville, MD, 2007."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.02.014"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.02.015"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(01)00261-6"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.02.002"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.72352"},{"key":"e_1_3_3_21_2","unstructured":"Wells G Shea B O'Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm. 2011 March 28."},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2010.03.025"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)33643-2"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(76)80041-8"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(84)90001-5"},{"key":"e_1_3_3_26_2","first-page":"205","article-title":"Impact of hormonal contraceptives vis-a-vis non-hormonal factors on the vitamin status of malnourished women in India and Thailand. World Health Organization: Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives","volume":"40","author":"Joshi UM","year":"1986","unstructured":"Joshi UM, , Virkar KD, , Amatayakul K et al. Impact of hormonal contraceptives vis-a-vis non-hormonal factors on the vitamin status of malnourished women in India and Thailand. World Health Organization: Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives. Hum Nutr Clin Nutr, 1986; 40:205\u2013220.","journal-title":"Hum Nutr Clin Nutr"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(86)90014-4"},{"key":"e_1_3_3_28_2","first-page":"361","article-title":"World Health Organization (WHO) Task Force on Oral Contraceptives","volume":"19","author":"Effects of hormonal contraceptives on breast milk composition and infant growth","year":"1988","unstructured":"Effects of hormonal contraceptives on breast milk composition and infant growth. World Health Organization (WHO) Task Force on Oral Contraceptives. Stud Fam Plann, 1988; 19:361\u2013369.","journal-title":"Stud Fam Plann"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/02724936.1992.11747569"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.123738"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5742.200"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(77)90045-2"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1997.02170420060010"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)38704-0"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0021932000010452"},{"key":"e_1_3_3_36_2","first-page":"513","article-title":"Norethisterone oenanthate and medroxyprogesterone acetate","volume":"15","author":"Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids:","year":"1977","unstructured":"Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids:. Norethisterone oenanthate and medroxyprogesterone acetate. Contraception, 1977; 15:513\u2013533.","journal-title":"Contraception"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0021932000012864"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(81)90056-1"},{"key":"e_1_3_3_39_2","first-page":"9","article-title":"Contraception during lactation","volume":"6","author":"Badraoui MH","year":"1982","unstructured":"Badraoui MH, , Hefnawi F, , Bahgat R et al. Contraception during lactation. Reproduccion, 1982; 6:9\u201318.","journal-title":"Reproduccion"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.78.2.210"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7292(87)90402-4"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7292(87)90395-X"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2008.12.014"},{"key":"e_1_3_3_44_2","first-page":"18","article-title":"Does \u201cDepo\u201d given prior to hospital discharge affect milk supply? A unanswered question","volume":"9","author":"Chantry CJ","year":"2003","unstructured":"Chantry CJ. Does \u201cDepo\u201d given prior to hospital discharge affect milk supply? A unanswered question. Acad Breastfeed Med News Views, 2003; 9:18\u201322.","journal-title":"Acad Breastfeed Med News Views"}],"container-title":["Breastfeeding Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/bfm.2011.0105","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/bfm.2011.0105","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/bfm.2011.0105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:59:37Z","timestamp":1777381177000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/bfm.2011.0105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,15]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2,1]]}},"alternative-id":["10.1089\/bfm.2011.0105"],"URL":"https:\/\/doi.org\/10.1089\/bfm.2011.0105","relation":{},"ISSN":["1556-8253","1556-8342"],"issn-type":[{"value":"1556-8253","type":"print"},{"value":"1556-8342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,15]]}}}